✦ LIBER ✦

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies

✍ Scribed by David M. Vail; Michael A. Amantea; Gail T. Colbern; Francis J. Martin; Ralf A. Hilger; Peter K. Working

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, efficacy and toxicity

✍ Rao N. V. S. Mamidi; Steve Weng; Susan Stellar; Charles Wang; Ning Yu; Tony Huan 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Quantification of pegylated liposomal do

✍ Yanhong Liu; Yuhui Yang; Xiangtao Liu; Tao Jiang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 501 KB

Dose Dependency of Pharmacokinetics and

✍ Gabizon, Alberto; Tzemach, Dinah; Mak, Lidia; Bronstein, Moshe; Horowitz, Aviva 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 379 KB

A phase II and pharmacokinetic study of

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB

An open-label study to evaluate dose and

✍ Alberto Gabizon; Rut Isacson; Ora Rosengarten; Dina Tzemach; Hilary Shmeeda; Ram 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 459 KB

A dose escalation and pharmacokinetic st

✍ Bozionelou, V; Vamvakas, L; Pappas, P; Agelaki, S; Androulakis, N; Kalykaki, A; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB